Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its antiviral research and development programs at IDWeek ...

Vietnam and Japan will deepen cooperation in healthcare, focusing on prioritised areas of strengths and growth potential.

Liver cancer is a growing global concern, affecting non-drinkers due to conditions like MASLD and MASH linked to lifestyle ...

A decade after a historic HIV outbreak in Indiana, syringe programs that helped contain the crisis are at risk of ...

Learn about the new California laws addressing pet rescue, transgender ID changes, and sterile syringes for disease ...

A major collaboration between UC San Diego and 23andMe identified genes that shape cannabis use behaviors. The study linked the CADM2 and GRM3 genes to cannabis use and connected these patterns to ...

SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced positive topline results from the BL-B01D1-301 trial. The trial has met one of the dual primary endpoints ...

The addition of tiragolumab to Tecentriq and Avastin did not significantly improve progression-free survival in ...

In a market environment where low interest rates have become the norm, income-focused investors are increasingly turning to ...

FDA approval based on superiority of Gazyva over standard therapy alone, as shown in Phase II NOBILITY and Phase III REGENCY data –– Gazyva is the only anti-CD20 monoclonal antibody to demonstrate a ...

Is it Vulval Lichen Sclerosus? A top gynecologist explains the chronic skin condition, including key symptoms (intense ...

Today's riddle: How do snowmen get their money? 🤔 (Answer below!) Weather forecast: Monday: Sunny, with ...